Cargando…

Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes

BACKGROUND: Paclitaxel treatment produces dose-limiting peripheral neurotoxicity, which adversely affects treatment and long-term outcomes. In the present study, the contribution of genetic polymorphisms to paclitaxel-induced neurotoxicity were assessed in 21 patients, focusing on polymorphisms invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Susanna B, Kwok, John B, Loy, Clement T, Friedlander, Michael L, Lin, Cindy S-Y, Krishnan, Arun V, Lewis, Craig R, Kiernan, Matthew C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364586/ https://www.ncbi.nlm.nih.gov/pubmed/25535399 http://dx.doi.org/10.1186/1471-2407-14-993

Ejemplares similares

Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
por: Hooshmand, Kosar, et al.
Publicado: (2022)

GSK3B and MAPT Polymorphisms Are Associated with Grey Matter and Intracranial Volume in Healthy Individuals
por: Dobson-Stone, Carol, et al.
Publicado: (2013)

Dose Effects of Oxaliplatin on Persistent and Transient Na(+) Conductances and the Development of Neurotoxicity
por: Park, Susanna B., et al.
Publicado: (2011)

Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel
por: Chiang, Jeremy Chung Bo, et al.
Publicado: (2021)

Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
por: Pan, Yiyuan, et al.
Publicado: (2018)

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
por: Coupland, Kirsten G., et al.
Publicado: (2016)

MAPT rs242562 and GSK3B rs334558 are associated with Parkinson’s Disease in central China
por: Yu, Lan, et al.
Publicado: (2014)

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
por: Forrest, Shelley L, et al.
Publicado: (2018)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

Progressive Axonal Dysfunction Precedes Development of Neuropathy in Type 2 Diabetes
por: Sung, Jia-Ying, et al.
Publicado: (2012)

MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies
por: Trabzuni, Daniah, et al.
Publicado: (2012)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
por: Tauber, Christina V., et al.
Publicado: (2023)

The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease
por: Jayapalan, Saranya, et al.
Publicado: (2013)

Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians
por: Huang, Yue, et al.
Publicado: (2015)

Regulation of human MAPT gene expression
por: Caillet-Boudin, Marie-Laure, et al.
Publicado: (2015)

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
por: Park, Susanna B., et al.
Publicado: (2012)

Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy
por: Mizrahi, David, et al.
Publicado: (2021)

MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD
por: Korn, Lisanne, et al.
Publicado: (2022)

MAPT association with REM sleep behavior disorder
por: Fernández-Santiago, Rubén, et al.
Publicado: (2017)

What’s in a Gene? The Outstanding Diversity of MAPT
por: Ruiz-Gabarre, Daniel, et al.
Publicado: (2022)

Mitochondrial Defects in Fibroblasts of Pathogenic MAPT Patients
por: Bharat, Vinita, et al.
Publicado: (2021)

Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

Rates of lobar atrophy in asymptomatic MAPT mutation carriers
por: Chen, Qin, et al.
Publicado: (2019)

Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
por: Li, Tiffany, et al.
Publicado: (2022)

A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer
por: Chiang, Jeremy Chung Bo, et al.
Publicado: (2021)

Emergence of a Predictive Clinical Biomarker for Diabetic Neuropathy
por: Kiernan, Matthew C.
Publicado: (2012)

Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2017)

Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2022)

Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease
por: Deutschlander, Angela B., et al.
Publicado: (2020)

The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
por: Sato, Junya, et al.
Publicado: (2016)

2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
por: Hertz, Daniel L., et al.
Publicado: (2018)

Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia
por: Park, Susanna B., et al.
Publicado: (2022)

Genetic risks of Alzheimer’s by APOE and MAPT on cortical morphology in young healthy adults
por: Huang, Weijie, et al.
Publicado: (2023)

Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy
por: Duggett, Natalie A., et al.
Publicado: (2016)

H1-MAPT and the Risk for Familial Essential Tremor
por: García-Martín, Elena, et al.
Publicado: (2012)

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
por: Corsi, Andrea, et al.
Publicado: (2022)

Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse
por: Andrés-Benito, Pol, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1dnun0obavqhip77ss73nbhneb